Lyell Immunopharma, Inc. (LYEL) reported Q3 Revenue

Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported Q3 Revenue for the quarter came in at $34 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Lyell Immunopharma, Inc. (LYEL) click here.

You May Also Be Interested In

• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
• Stripe, Advent In Talks To Buy Paypal - WSJ
• Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy